Psivida wins technology award

By Melissa Trudinger
Thursday, 15 July, 2004

Nanotechnology company Psivida (ASX: PSD) has had its research applying its BioSilicon technology to drug delivery, diagnostics, orthopaedics and tissue engineering recognised with a 2004 Excellence in Research Award from US consulting group Frost & Sullivan.

Frost & Sullivan announced the award in a recently released study focusing on nanomedicine.

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...

Archer completes potassium sensing alpha prototype

Quantum technology company Archer Materials Limited has developed an early Biochip prototype...

Farm animals and aquaculture cryopreservation partnership announced

Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...

Content from other channels on our network

Fonterra announces Mainland Group leadership change

Barry Callebaut opens chocolate innovation centre in Singapore

Natto your average Japanese superfood

Suntory Oceania appoints new CMO

What's on trend for the packaging sector in 2026?

How do different types of pain influence empathy?

St Vincent's Hospital Sydney junior doctors class action underway

Hospital waiting times remain high, new Productivity Commission data reveals

From vision to vigilance: building a secure digital future for health care

The Emergency Department Access & Performance Conference

Video-based water detection reduces contamination in gas pipeline

Government finalises Net Zero Fund design

Seeing with AI: flexible navigation in dynamic environments with Visual SLAM

BioCarbon secures funding to commercialise biochar coke

Schneider Electric moves towards SDA with new DCS